Skip to main content
. 2018 May 3;361:k1332. doi: 10.1136/bmj.k1332

Table 5.

Adverse events by treatment allocation. Values are numbers (percentages)

Adverse events by follow-up Bath additives (n=252) No bath additives (n=209)
16 weeks:
 Slipping in bath 44 (17) 52 (25)
 Stinging 4 (2) 4 (2)
 Redness 35 (14) 48 (23)
 Refusal to bathe 21 (8) 25 (12)
52 weeks:
 Slipping in bath 56 (22) 63 (30)
 Stinging 7 (3) 4 (2)
 Redness 44 (17) 61 (29)
 Refusal to bathe 30 (12) 31 (15)